Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies.
Saved in:
| Title: | Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies. |
|---|---|
| Authors: | Bonato V; Nonclinical Statistics, Pfizer Inc, La Jolla, California, USA., Tang SY; Nonclinical Statistics, Pfizer Inc, La Jolla, California, USA., Hsieh M; Global Data & Analytics, Rakuten Medical, San Diego, California, USA., Zhang Y; Nonclinical Statistics, Pfizer Inc, Cambridge, Massachusetts, USA., Deng S; Statistical Research and Data Science Center, Pfizer Inc, La Jolla, California, USA. |
| Source: | Pharmaceutical statistics [Pharm Stat] 2025 Jan-Feb; Vol. 24 (1), pp. e2399. Date of Electronic Publication: 2024 Jun 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
